Biotech executive Clare Hildred has been appointed ceo of IP-driven company Chromatide.
She has a track record of delivering value and business change in high growth customer focused organisations and previously worked as finance and business improvement director at Avecia Biotechnology where she was involved in major contract negotiations, leading operational change projects and where she held senior financial management positions.